Target intelligence / Profile preview

Nuclear factor erythroid 2-like 1 (NFE2L1)

Target
NFE2L1
Molecular classification
Transcription factor, CNC-bZIP (cap ‘n’ collar basic leucine zipper) family protein
01

Overview

Nuclear factor erythroid 2-like 1 (NFE2L1, often referred to as Nrf1 or TCF11) is a member of the CNC-bZIP family of transcription factors, ubiquitously expressed and essential for regulating cellular homeostasis[1][2][5]. It anchors to the endoplasmic reticulum membrane until stress signals induce its proteolytic processing and nuclear translocation, where it activates genes involved in oxidative stress defense, protein degradation (proteasome subunits), and lipid metabolism[1][3][5]. NFE2L1 maintains cell viability by safeguarding proteostasis and modulating the antioxidant response, supporting functions in development, tissue regeneration, cancer prevention, bone remodeling, and neuroprotection[2][3][5]. Loss of NFE2L1 function results in severe phenotypes, including embryonic lethality and susceptibility to neurodegeneration or liver tumorigenesis in animal models[5]. Unlike membrane-bound receptors or enzymes, NFE2L1 acts in the nucleus as a master regulator of cellular adaptive programs[1][2][3][5].

Other names
Nrf1TCF11NF-E2-related factor 1
02

Mechanism of action

Activation of antioxidant response element (ARE)–dependent genes to induce cytoprotective programs; Induction of proteasome subunit genes to restore proteasome activity under stress

03

Biological functions

Regulation of oxidative stress responseProteostasis (protein homeostasis)Lipid and cholesterol metabolismInflammatory response regulationCell differentiationRegulation of proteasome gene expressionCellular stress responseDNA repair
04

Disease associations

CancerNeurodegenerative diseaseMetabolic diseaseLiver disordersBone remodeling disorders
05

Safety considerations

Risk of disrupting proteostasis (protein homeostasis) with inhibitionPossible unintended effects on oxidative stress response and cellular differentiationEmbryonic lethality in knockout models indicates a broad and essential role in development and tissue maintenance[5]
06

Interacting drugs

None specifically approved or established as direct modulators; as a transcription factor, it is not a classic drug target, but some experimental agents that modulate proteasome function or oxidative stress (e.g., proteasome inhibitors, modulators of cellular stress pathways) may influence its activity indirectly[2][4][3]
07

Biomarkers

Expression/activity of NFE2L1 for cellular stress response, potentially for monitoring proteostasis, certain cancers, or neurodegenerative states[2][5]

Beyond the preview

Go deeper on Nuclear factor erythroid 2-like 1 (NFE2L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear factor erythroid 2-like 1 (NFE2L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call